Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pietrantonio

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
ESMO Open|January 18, 2021
Predictive role of microsatellite instability for PD-1 blockade in patients with advanced gastric cancer: a meta-analysis of randomized clinical trialsF Pietrantonio, G Randon, M Di Bartolomeo, et al.
ESMO Open|June 4, 2024
Systemic treatment of mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer-single versus double checkpoint inhibitionD Marinelli, A Sabatini, E Bengala, et al.
Contact Dermatitis|March 1, 1993
Repeated patch testing in delayed hypersensitivity to beta-lactam antibioticsA Romano, M Di Fonso, F Pietrantonio, et al.
Applied and Environmental Microbiology|July 2, 1999
Physiological adaptations involved in alkane assimilation at a low temperature by Rhodococcus sp. strain Q15L G Whyte, S J Slagman, F Pietrantonio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 9, 2026
The Inflammatory Biomarkers Prognostic Index (IBPI) obtained from standard preoperative blood tests predicts postoperative complications in patients undergoing pelvic exenteration for locally recurrent rectal cancerA Scardino, M Fiore, T Cavalleri, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 25, 2026
Immune Checkpoint Inhibitor Therapy for Advanced, Unresectable Esophageal Squamous Cell Carcinoma: A Series of Patient-level Meta-analyses From Phase III TrialsM S Beshr, R H Shembesh, M V Nounou, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2012
Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patientsF Pietrantonio, P Biondani, M Milione, et al.
ESMO Open|October 30, 2025
Negative hyperselection of patients with stage III colon cancer receiving anti-EGFR-based adjuvant treatmentM Ambrosini, H Blons, S Garinet, et al.
ESMO Open|February 23, 2024
Gender oncology: recommendations and consensus of the Italian Association of Medical Oncology (AIOM)R Berardi, F Rossi, R Papa, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Early- and advanced-stage MSI-H non-colorectal cancers: best management and challenges in 2025R Fazio, M Ambrosini, A Raimondi, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
ESMO Open|January 18, 2021
Predictive role of microsatellite instability for PD-1 blockade in patients with advanced gastric cancer: a meta-analysis of randomized clinical trialsF Pietrantonio, G Randon, M Di Bartolomeo, et al.
ESMO Open|June 4, 2024
Systemic treatment of mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer-single versus double checkpoint inhibitionD Marinelli, A Sabatini, E Bengala, et al.
Contact Dermatitis|March 1, 1993
Repeated patch testing in delayed hypersensitivity to beta-lactam antibioticsA Romano, M Di Fonso, F Pietrantonio, et al.
Applied and Environmental Microbiology|July 2, 1999
Physiological adaptations involved in alkane assimilation at a low temperature by Rhodococcus sp. strain Q15L G Whyte, S J Slagman, F Pietrantonio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 9, 2026
The Inflammatory Biomarkers Prognostic Index (IBPI) obtained from standard preoperative blood tests predicts postoperative complications in patients undergoing pelvic exenteration for locally recurrent rectal cancerA Scardino, M Fiore, T Cavalleri, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 25, 2026
Immune Checkpoint Inhibitor Therapy for Advanced, Unresectable Esophageal Squamous Cell Carcinoma: A Series of Patient-level Meta-analyses From Phase III TrialsM S Beshr, R H Shembesh, M V Nounou, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 27, 2012
Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patientsF Pietrantonio, P Biondani, M Milione, et al.
ESMO Open|October 30, 2025
Negative hyperselection of patients with stage III colon cancer receiving anti-EGFR-based adjuvant treatmentM Ambrosini, H Blons, S Garinet, et al.
ESMO Open|February 23, 2024
Gender oncology: recommendations and consensus of the Italian Association of Medical Oncology (AIOM)R Berardi, F Rossi, R Papa, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Early- and advanced-stage MSI-H non-colorectal cancers: best management and challenges in 2025R Fazio, M Ambrosini, A Raimondi, et al.
Pageof 8